Residential Rehab

California’s 911 Good Samaritan overdose law provides limited protection from certain possession-related criminal liability when someone seeks medical help in good faith for a drug-related overdose.

In California, naloxone can be obtained through pharmacies, over-the-counter nasal products, community organizations, syringe-service and harm-reduction programs, and other distribution channels supported by state public-health programs.

Xylazine test strips are drug-checking tools designed to detect xylazine in a drug sample. They can indicate the presence of xylazine but do not measure dose, purity, or every possible contaminant.

Drug checking uses test strips, spectroscopy, or laboratory analysis to identify some substances in an unregulated drug sample so people can make safer decisions and connect with harm-reduction or treatment services.

EtG and PEth are both direct alcohol biomarkers, but EtG is commonly used to detect more recent alcohol exposure while PEth is a blood-based marker that can reflect alcohol use over a longer period.

A PEth blood test measures phosphatidylethanol, a direct alcohol biomarker that forms in blood in the presence of ethanol and can reflect alcohol exposure over a longer window than breath or blood alcohol testing.

An EtG test looks for ethyl glucuronide, a direct metabolite of alcohol that can remain detectable after ethanol itself is no longer measurable.

Protracted benzodiazepine withdrawal refers to withdrawal-related symptoms that persist beyond the expected acute withdrawal period after benzodiazepine reduction or discontinuation.

Cocaine withdrawal can cause fatigue, depressed mood, sleep changes, increased appetite, slowed thinking, anxiety, irritability, anhedonia, and cravings. Treatment focuses on safety, support, and ongoing care for stimulant use disorder.

Methamphetamine withdrawal can cause fatigue, depression, sleep changes, increased appetite, anxiety, irritability, and cravings. Treatment focuses on assessment, safety, sleep, nutrition, and ongoing care for stimulant use disorder.